Metals are cytotoxic and could be harmful to human health; however, as their effects are dose dependent, some of them could be used in chemotherapy. In the present work, mineral chromium (VI) showed that it is cytotoxic on both tumour HeLa, and non-tumour ( The role of formyl and methoxy groups in arene tricarbonylchromium is shown in complexes acquiring the selective tumour cytotoxicity.
Metals are commonly considered as toxic to living organisms. Beryllium, cadmium, chromium, and nickel are among metals that are classified as carcinogenic.
Many chromium compounds were shown to induce tumours in animals and many epidemiologic studies showing risks of developing cancer were reported from workers exposure [1] .
In particular, the tumour targets of chromium (VI) are essentially lung, nasal cavity and paranasal sinuses caused by inhalation. The major effects of chromium (VI) are mutations, genomic instability, aneuploidy, cell transformation [2] , DNA cross-links reported in rat liver and Kidney [3] , direct DNA damage in chick embryo hepatocytes [4] and other genetic effects [5] . Meanwhile the DNA damage related to chromium (VI) compounds depends on the reduction to reactive species by cellular redox components [6] .
No evidence of carcinogenesis risk by the oral route of chromium (VI) and in drinking water; the international guidelines of WHO allow a maximum hexavalent chromium concentration at 0.05 mg/L [7] which corresponds to 1 μM.
Moreover, Levis and Majone (1979) studied the cytotoxicity of 11 hydrosoluble chromium compounds and showed that all of them inhibited non-tumour cell lines of hamster [8] .
By contrast to the toxicity effects, some metal ions are indispensable for vital reactions in living cells. In general, these metals are embedded in organic molecules such as cobalt in vitamin B6, iron in haemoglobin and Mg 2+ , Zn 2+ , Mn 2+ playing the role of cofactors for many enzymes. It has been found that some metals are involved in chemical complexes that can be used as radiation protective agents [9] and as medicines such as Zn-diethylentriamine pentaacetate, approved by Food and Drug Administration (FDA), for the elimination of known or suspected internal contamination with the transuranic metals (Z > 92) plutonium, americium, and curium.
The success story of metal compounds in cancer therapy started with the discovery of cisplatin and its derivatives by Rosenberg. In fact, they were able to reduce solid and blood tumours in animals [10] . Between toxic effects and the benefits of metallic ions in life processes, the synthesis of organometallics was installed as a discipline combining metals and organic chemicals in order to produce new alternatives for bioactive molecules. This promising field of research is named "Bioorganometallic chemistry" [12] .
Organometallic compounds have been extensively studied for their applications in medicine over the last two decades [13] [14] [15] [16] [17] [18] . The first fruit was arsphenamine (Salvarsan), which is based on arsenic (despite its unfavourable reputation as poison) and azobenzene, serving for the treatment of syphilis and trypanosomiasis. This is how Dr. Ehrlich's Magic
Bullet was born and initiating the concept of chemotherapy [19] .
The complexes of Fe [20] [21] [22] [23] , Ru [24] [25] [26] , Os [27, 28] and Ag [29] have been found to be very active against cancer cells. Arene tricarbonylchromium group, for which the oxidation state of chromium is zero, has been attached to biological substances such as β-estradiol molecule to produce complexes that have been mainly studied for their capacity to act as a probe for the detection of biological substances by infrared spectroscopy [30] . One of the chromium complexes was recognized by androgen receptor [31] . It has been found that tricarbonylchromium compounds can release carbon monoxide for application in therapy.
This type of compounds is known as CO-releasing molecules (CORMs) [32, 33] . However, their use as antitumour agents has not been well developed. For this reason, we have examined some arene tricarbonylchromium complexes for their cytotoxic activity towards four tumour cell lines and one non-tumour cell line Hek293 (Human embryonic kidney cells 293) in order to select new potential anticancer drugs. MCF-7, Caco-2, Hep2, HeLa and HEK293 cell lines were grown in DMEM supplemented with 10% foetal bovine serum, 50 IU/ml penicillin, 50 mg/ml streptomycin at 37 °C in a humidified 5% CO 2 atmosphere.
Materials and methods

Cell lines and cultures
Chemical compounds
K 2 Cr 2 O 7 is purchased from Sigma-Aldrich.
Compounds 1 [34] , 2 [35] , and 3 [36] were synthesized according to the literature procedures. The synthesis of Rac-1, 2-bis (hydroxyethyl)-benzenetricarbonylchromium 4 was published by Besançon et al. [37] .
The synthesis of compounds 5 [38] , 6 and 7 [39] has been published in literature.
Inorganic chromium K 2 Cr 2 O 7 and organic chromium chemical compounds were solubilised in DMSO at the concentration of 165 mM. Just before treatment, each stock solution was diluted at the appropriate concentration.
Proliferation assay
Cells were grown in 96-well plates until 40% confluence. Then, the tested compound at the appropriate concentrations was added and incubated for 48 h.
Cell viability was tested using the MTT assay against several cell lines as previously described by Mosmann [40] . This assay is based on the reduction of MTT into purple formazan crystals by the succinate dehydrogenase enzyme in the mitochondrial respiratory chain.
After treatment, the medium was removed and replaced with 100 μL of fresh medium and 10 μL of MTT solution (5 mg/mL in PBS). Four hours later, 100 μL of 10% SDS solution were added to each well to dissolve the formazan. The optical density was evaluated at 570 nm using a Varioskan microplate reader (Thermofisher). The growth inhibition was expressed as follows: (%) cell survival = (AT/A0) ×100; where A0 is the control absorbance and AT the absorbance of the treated cells.
Morphological changes
Cells were plated in 24-well plates at 5 × 104 cells/mL and grown for 24 h.
Furthermore, cells were incubated in the presence of chromium compound at IC 50 concentration and incubated 48 h.
Then, cells in culture were stained with methylene blue during 1 h, viewed with phase contrast microscopy and photographed.
DNA fragmentation analysis for detecting apoptosis
All the cultured cell lines were treated separately by IC 50 and lethal doses of each tested compound. After 24 h, cells were harvested by centrifugation, washed by PBS1x and suspended in lysis buffer (20 mM EDTA -100 mM Tris-HCl pH 8.0, 1% SDS) containing 100 μg/mL RNase and incubated overnight at 55 °C. Proteinase K (100 μg/mL) was added and incubated 2 h at 37 °C. DNA was then precipitated with 2.5 vol of absolute ethanol and finally dissolved in Tris-EDTA pH8 after centrifugation. DNA samples were analyzed by electrophoresis on 1.5% agarose gel.
Statistical analysis
The data were summarized as the mean ± SD of six independent experiments. Statistical comparisons for all experiments were performed using unpaired Student's test and the level of significance was set at P ≤ 0.05.
Results
Chemical compounds
Arene tricarbonylchromium compounds are organometallics produced by a complexation of arenes tricarbonylchromium group. 7 compounds were selected: formyl benzene tricarbonylchromium 1 [34] , anisol tricarbonylchromium 2 [35] , trimethoxybenzene tricarbonylchromium 3 [36] rac-1, 2-bis (hydroxyethyl)-benzenetricarbonylchromium 4 [37] , N-(1-phenylethyl)acetamido tricarbonylchromium 5 [38] , and two bis-tricarbonylchromium respectively alcohol and ketone 6 and 7 [39] . The structure of the present compounds are summarized in Fig. 1 . The results showed clearly that the inhibition of cell growth was dose -dependent and increased while increasing the concentration of the used compound. The IC 50 values are presented in Table 1 and Fig. 3 . 
Morphological changes
When treated with the chromium molecules, the different cell lines presented morphological changes. These changes are followed in Hep2, HeLa, Caco-2 and MCF-7 treated with the IC 50 of each compound. In fact, treated cells became rounded and pyknotic and many of them are detached from their substratum while untreated cells grew adherently on culture plates (Fig. 4) . 
DNA fragmentation analysis for detection of apoptosis
Cells were treated with chromium compounds at IC 50 and lethal concentrations before DNA extraction and analysis on agarose gel electrophoresis.
All tested compounds provoked DNA fragmentation when cells were treated at IC 50 or lethal concentrations during 24 h. Fig. 5 shows an example of cell fragmentation. This result confirmed an apoptotic effect. 
Discussion
The benefits of metals, particularly in human health or in human life activities, are hindered by their toxicity. Many applications of metals are avoiding the harmful doses but they are not all the time getting the needed efficiency like inorganic pesticides based on arsenic, copper sulfates, lead, mercury that are causing serious soil toxicity [41, 42] .
As expected, in the present work, the mineral chromium (K were the lowest without any distinction between the non-tumour cell line and tumour cell lines (Table 1) . Our results confirm the toxicity of mineral chromium (VI), already described, on non-tumour cells lines such as HBK and CHO of Hamster [8] . Moreover, the apoptotic effect of K 2 Cr 2 O 7 was previously described in nonsmall-cell-lung cancer cell line [11] . We noticed a more pronounced toxicity on the nontumour cell line HEK293 showing the lowest IC 50 value of 1.41 μM that corresponds to 0.073 mg/L which is slightly superior to 0.05 mg/L the allowed chromium contamination in water according to WHO [7] .
Organometallic chemistry was developed to benefit from metals while decreasing their toxicity thanks to their incorporation in adequate organic molecules. In our work, this approach was confirmed: the synthesized organometallics harbouring chromium are displaying less toxicity to all the cell lines than K 2 Cr 2 O 7 especially on the non-tumour cells (Fig. 3) .
The comparison between the most efficient compounds revealed the importance of the aldehyde group in the arene tricarbonylchromium 1 which, among all the complexes, is
showing the best specific toxicity on HeLa and MCF-7 compared to the non-tumour HEK293 cells. Meanwhile, compound 2 despite its low toxicity against HeLa, is the most toxic on the other cancer cell lines than all the remaining complexes giving rise to 4, 5 and 10 times toxicity respectively on Caco2, Hep2 and MCF-7 compared to HEK293 cells. It seems that the methoxy group reinforced the specific cytotoxicity of compound 2 but the presence of 3 methoxy groups on compound 3 was decreasing the toxicity against all cancer cell lines.
In the other hand, the methylcarbinol group of arene tricarbonylchromium 4 decreased the toxicity against tumour cells that became higher on HEK293 except on HeLa cells. The same conclusion is valid for compounds 5, containing the phenyl-CHNHCOCH3, and 6, a bistricarbonylchromium containing >CHOH between the two arenes; both compounds lack the tumour specific toxicity. The dimeric arene tricarbonylchromium 7 differs from 6 just by substituting the >CHOH separating the two monomers by a >C=O and -NH 2 group on one arene; interestingly, 7 is acquiring a specific cytotoxicity against Hep2 cells.
To summarise, these results showed that compounds 1, 2 and 3 play a selective toxicity on tumour cell lines while 4, 5, 6 and 7 are, in general, more toxic to the non-tumour cell line.
Moreover, based on these results, 1 could be selected as a potential candidate for the treatment of cervical and breast cancer represented by HeLa and MCF-7 cell lines and 2 could be a good candidate to treat breast cancer according to the results obtained with MCF-7 cell line.
Finally, compounds 3 and 7 could be good candidates for cervical cancer represented by Hep-2 cell line.
All compounds tested in the present work have arene tricarbonylchromium as a common structure but with different attached chemical groups.
Conclusion
We have selected 7 arene tricarbonylchromium compounds to study their antitumour Therefore, in the future we intend to diversify the functional chemical groups attached to the arene tricarbonylchromium in order to generate a more interesting anti-cancer activity and select the best combinations that preserve normal cells intact and ultimately to understand the peculiar activity of this type of organometallics. In this context, the presence of a formyl and a methoxy groups in the same arene tricarbonylchromium could be very interesting in terms of tumour cytotoxicity.
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